Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. (EGX:RMDA)
Egypt flag Egypt · Delayed Price · Currency is EGP
4.400
+0.130 (3.04%)
At close: Mar 27, 2025

EGX:RMDA Revenue

In the year 2024, Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. had annual revenue of 2.77B EGP with 44.03% growth. Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. had revenue of 984.32M in the quarter ending December 31, 2024, with 84.26% growth.

Revenue
2.77B
Revenue Growth
+44.03%
P/S Ratio
2.38
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.62B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20242.77B846.34M44.03%
Dec 31, 20231.92B438.40M29.54%
Dec 31, 20221.48B237.52M19.06%
Dec 31, 20211.25B286.27M29.81%
Dec 31, 2020960.17M66.20M7.41%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition